Compare Medpace Holdings Inc (MEDP) vs Quanta Services Inc (PWR) Price & Performance

MEDP trades at $527.93, down 1.82% today, with a bullish technical outlook supported by moving averages. The company demonstrates strong profitability with 17.19% net margins and 77.25% ROE, though valuation ratios appear elevated with a P/E of 33.83. Recent earnings have consistently beaten expectations, and cash flow is projected to improve significantly in 2026. However, the stock faces headwinds from ongoing class action lawsuits and mixed analyst sentiment with 73.69% hold ratings.

MEDP presents a mixed investment case with strong fundamental performance offset by legal overhangs and premium valuation. The company's consistent earnings beats and projected cash flow improvement support upside potential, but investors should weigh the legal risks and cautious analyst stance against the robust operational metrics.

PWR trades at $633.04, up 0.72% today, with strong analyst support (27 Buy, 0 Sell) and a consensus price target of $836.80. Recent quarters show consistent EPS beats, with Q1 2026 actual of $2.68 exceeding the $2.04 estimate. Revenue growth is robust, climbing from $17.1B in 2022 to $28.5B in 2025, though net margins remain modest at 3.67%. Technical indicators are mixed, with a bearish overall signal but bullish oscillators like RSI near oversold levels.

The outlook is positive due to infrastructure demand from AI and grid modernization, with a projected $2.4T addressable market by 2030. Risks include high valuation multiples (P/E 86.22) and aggressive capital spending impacting cash flow. Institutional sentiment is bullish, but execution risks and economic cycles could pressure near-term performance.